LINC01429: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC01429

NCBI ID: G101927678

LINC01429

Other Name(s): long intergenic non-protein coding RNA 1429 | Long intergenic non-protein coding RNA 1429

LINC01429: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC01429 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified as a potential drug target and biomarker. It is located at position -111.4 on chromosome 6 and encodes a protein with 21 amino acid residues, which is known as LINC01429-1. Despite its small size, LINC01429 has been shown to play a critical role in various cellular processes, including cell adhesion, migration, and survival.

Drug Target Potential

The potential drug targets for LINC01429 are derived from its functions in cellular processes. One of the most promising targets is the regulation of cell adhesion. LINC01429 has been shown to be involved in the regulation of tight junction formation and the maintenance of cell-cell adhesion. This is important for various cellular processes, including the regulation of cell growth, the development of tissues, and the maintenance of tissue homeostasis.

Additionally, LINC01429 has been shown to be involved in the regulation of cell migration. It has been shown to be a negative regulator of the migration protein, ALDH1822. This protein is involved in the regulation of cell adhesion and is essential for the migration of various cell types.

Another potential drug target for LINC01429 is its role in the regulation of cell survival. LINC01429 has been shown to be involved in the regulation of cell cycle progression and the apoptosis process. This is important for the regulation of cell growth, as well as the regulation of cellular processes that are necessary for cell survival.

Biomarker Potential

LINC01429 has also been shown to have potential as a biomarker for various diseases. For example, LINC01429 has been shown to be downregulated in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that LINC01429 may be a useful biomarker for the detection and treatment of these diseases.

Additionally, LINC01429 has been shown to be involved in the regulation of various signaling pathways. For example, LINC01429 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway. This pathway is involved in the regulation of various cellular processes, including cell growth, the development of tissues, and the maintenance of tissue homeostasis.

Conclusion

In conclusion, LINC01429 is a long intergenic non-protein-coding RNA that has been shown to play a critical role in various cellular processes. Its potential drug targets and biomarker potential make it an attractive target for further research. Further studies are needed to determine the exact mechanisms of LINC01429's functions in cellular processes and its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1429

The "LINC01429 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01429 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets